| Literature DB >> 32952135 |
Luis Gustavo Sabino Borges1, Maria Flávia Meirelles1, Natália Bernardes1, Felipe Lopes de Castro1, Fernanda Rodrigues Helmo1, Laura Penna Rocha1, Vicente de Paula Antunes Teixeira1, Rosana Rosa Miranda Correa1.
Abstract
INTRODUCTION: Histopathological analysis of the foreskin has become more common in the last two decades.Entities:
Keywords: Annexin 1; Langerhans cells; corticosteroids; phimosis
Year: 2019 PMID: 32952135 PMCID: PMC7759080 DOI: 10.4103/ajps.AJPS_119_16
Source DB: PubMed Journal: Afr J Paediatr Surg ISSN: 0974-5998
Figure 1Analysis of the foreskin in pediatric patients undergoing surgery for circumcision. (a) Comparison of the number of elastic fibers between groups with and without previous complications (balanoposthitis). (b) Comparison of the epidermal thickness in three areas of the foreskin. Significant differences: Middle foreskin versus other groups. (c) Comparison of the amount of Annexin between groups with and without previous complications (balanoposthitis). (d) Density of mature Langerhans cells and immature Langerhans cells in samples of foreskin. The error bars represent the standard deviation
Morphological and Immunohistochemical Analyses of the Foreskin in Children with Phimosis
| Groups | Elastic fibers (%), Mean±SD | Annexin (%), Mean±SD | Epidermal thickness (µm), Mean±SD | LCs density (cells/mm2), Mean±SD | |
|---|---|---|---|---|---|
| Complications | |||||
| No | 36 (90) | 29.63±7.09 | 16.80±6.29 | 151.58±27.24 | 12.82±4.45 |
| Yes | 4 (10) | 32.13±4.42 | 24.23±2.43 | 155.23±31.49 | 11.13±2.97 |
| Total | 40 (100) | ||||
| 0.688, 0.496 | 2.347, 0.024 | 0.251, 0.803 | 0.736, 0.466 | ||
| Topical corticotherapy | |||||
| No | 22 (55) | 30.24±6.95 | 18.38±6.31 | 150.46±27.10 | 11.30 (9.81-15.03) |
| Yes | 18 (45) | 29.45±6.94 | 16.53±6.42 | 153.74±29.02 | 11,15 (10.01-14.98) |
| Total | 40 (100) | ||||
| 0.360, 0.721 | 0.919, 0.364 | 0.364, 0.718 | 331.000, 0.810 | ||
| Therapeutic response | |||||
| No treatment | 22 (55) | 30.24±6.95 | 18.38±6.31 | 150.46±27.10 | 11.30 (9.81-15.03) |
| No response | 15 (37.5) | 29.93±6.46 | 16.86±6.35 | 151.81±29.30 | 11.07 (9.27-14.83) |
| Improve | 3 (2.5) | 27.05±10.35 | 14.83±7.90 | 162.76±31.76 | 11.15 (1063-14.64) |
| Total | 40 (100) | ||||
| 0.275, 0.761 | 0.539, 0.588 | 0.511, 0.604 | H=0.244 | ||
LC: Langerhans cells, DP: standard deviation